ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,172.16
0.61%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) News

Revolution Medicines (RVMD)

Revolution Medicines Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVMD
DateTimeSourceHeadlineSymbolCompany
08/05/202421:02GlobeNewswire Inc.Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
01/05/202421:05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024NASDAQ:RVMDRevolution Medicines Inc
09/04/202420:34GlobeNewswire Inc.Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) ProteinsNASDAQ:RVMDRevolution Medicines Inc
08/04/202416:36GlobeNewswire Inc.Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) ProteinsNASDAQ:RVMDRevolution Medicines Inc
04/04/202421:05GlobeNewswire Inc.Revolution Medicines to Participate in Upcoming Investor ConferencesNASDAQ:RVMDRevolution Medicines Inc
28/03/202420:05GlobeNewswire Inc.Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024NASDAQ:RVMDRevolution Medicines Inc
05/03/202421:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
05/03/202421:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
05/03/202421:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
04/03/202422:23Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:RVMDRevolution Medicines Inc
26/02/202422:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RVMDRevolution Medicines Inc
26/02/202421:05GlobeNewswire Inc.Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
26/02/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
20/02/202421:05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024NASDAQ:RVMDRevolution Medicines Inc
09/02/202422:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RVMDRevolution Medicines Inc
01/02/202421:05GlobeNewswire Inc.Revolution Medicines to Participate in Upcoming Investor ConferencesNASDAQ:RVMDRevolution Medicines Inc
24/01/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
22/01/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/01/202419:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
04/01/202412:00GlobeNewswire Inc.Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RVMDRevolution Medicines Inc
20/12/202322:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
20/12/202322:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
14/12/202323:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
14/12/202322:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
20/11/202323:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
20/11/202321:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
16/11/202319:58Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:RVMDRevolution Medicines Inc
15/11/202321:04Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:RVMDRevolution Medicines Inc
15/11/202301:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
15/11/202301:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:RVMD

Your Recent History

BITMOT
802380
Austria Tf 1,5% Nv86 Eur
COIN
AGRSBTC
Agoras Token
ASX
BMT
Beamtree
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved